Benzodioxane-Benzamides as FtsZ Inhibitors : Effects of Linker's Functionalization on Gram-Positive Antimicrobial Activity
FtsZ is an essential bacterial protein abundantly studied as a novel and promising target for antimicrobials. FtsZ is highly conserved among bacteria and mycobacteria, and it is crucial for the correct outcome of the cell division process, as it is responsible for the division of the parent bacterial cell into two daughter cells. In recent years, the benzodioxane-benzamide class has emerged as very promising and capable of targeting both Gram-positive and Gram-negative FtsZs. In this study, we explored the effect of including a substituent on the ethylenic linker between the two main moieties on the antimicrobial activity and pharmacokinetic properties. This substitution, in turn, led to the generation of a second stereogenic center, with both erythro and threo isomers isolated, characterized, and evaluated. With this work, we discovered how the hydroxy group slightly affects the antimicrobial activity, while being an important anchor for the exploitation and development of prodrugs, probes, and further derivatives.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Antibiotics (Basel, Switzerland) - 12(2023), 12 vom: 08. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Suigo, Lorenzo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1,4-benzodioxane |
|---|
| Anmerkungen: |
Date Revised 10.02.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/antibiotics12121712 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366274058 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366274058 | ||
| 003 | DE-627 | ||
| 005 | 20240210233017.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/antibiotics12121712 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1287.xml |
| 035 | |a (DE-627)NLM366274058 | ||
| 035 | |a (NLM)38136746 | ||
| 035 | |a (PII)1712 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Suigo, Lorenzo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Benzodioxane-Benzamides as FtsZ Inhibitors |b Effects of Linker's Functionalization on Gram-Positive Antimicrobial Activity |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a FtsZ is an essential bacterial protein abundantly studied as a novel and promising target for antimicrobials. FtsZ is highly conserved among bacteria and mycobacteria, and it is crucial for the correct outcome of the cell division process, as it is responsible for the division of the parent bacterial cell into two daughter cells. In recent years, the benzodioxane-benzamide class has emerged as very promising and capable of targeting both Gram-positive and Gram-negative FtsZs. In this study, we explored the effect of including a substituent on the ethylenic linker between the two main moieties on the antimicrobial activity and pharmacokinetic properties. This substitution, in turn, led to the generation of a second stereogenic center, with both erythro and threo isomers isolated, characterized, and evaluated. With this work, we discovered how the hydroxy group slightly affects the antimicrobial activity, while being an important anchor for the exploitation and development of prodrugs, probes, and further derivatives | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 1,4-benzodioxane | |
| 650 | 4 | |a Bacillus subtilis | |
| 650 | 4 | |a Gram-positive-dependent diseases | |
| 650 | 4 | |a antimicrobial resistance | |
| 650 | 4 | |a benzamide | |
| 650 | 4 | |a cell division protein FtsZ | |
| 650 | 4 | |a multidrug-resistant Staphylococcus aureus | |
| 700 | 1 | |a Margolin, William |e verfasserin |4 aut | |
| 700 | 1 | |a Ulzurrun, Eugenia |e verfasserin |4 aut | |
| 700 | 1 | |a Hrast Rambaher, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Zanotto, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Sebastián-Pérez, Victor |e verfasserin |4 aut | |
| 700 | 1 | |a Campillo, Nuria E |e verfasserin |4 aut | |
| 700 | 1 | |a Straniero, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Valoti, Ermanno |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antibiotics (Basel, Switzerland) |d 2012 |g 12(2023), 12 vom: 08. Dez. |w (DE-627)NLM243235135 |x 2079-6382 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:12 |g day:08 |g month:12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/antibiotics12121712 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 12 |b 08 |c 12 | ||